Berten Ceulemans

11.1k citations

155 papers · 5.5k · 2 hit papers · h-index 41

Impact in

Psychiatry and Mental health top 0.2%
- Epilepsy research and treatment
Cellular and Molecular Neuroscience top 1%
- Neuroscience and Neuropharmacology Research

Papers in

Psychiatry and Mental health 65
- Epilepsy research and treatment 61
Pediatrics, Perinatology and Child Health 33
- Pharmacological Effects and Toxicity Studies 20

Co-authors: Lieven Lagae (47 shared papers)Peter De Jonghe (13 shared papers)Lieve Claes (6 shared papers)Christine Van Broeckhoven (7 shared papers)Jurgen Del‐Favero (5 shared papers)An‐Sofie Schoonjans (25 shared papers)Anouk Van de Vel (20 shared papers)Bart Vanrumste (22 shared papers)
Journals: European Journal of Paediatric Neurology (18 papers)Epilepsia (12 papers)Seizure (10 papers)Developmental Medicine & Child Neurology (5 papers)Epilepsy & Behavior (5 papers)
Partner nations: Belgium United States Netherlands

In The Last Decade

Berten Ceulemans

153 papers receiving 5.4k citations

Berten Ceulemans's Hit Papers

align trajectories log scale

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial 2019 · 257 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 The Lancet
2001 The American Journal of Human Genetics

Peers

Countries citing papers authored by Berten Ceulemans

Since Specialization

Citations

This map shows the geographic impact of Berten Ceulemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berten Ceulemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berten Ceulemans more than expected).

Fields of papers citing papers by Berten Ceulemans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berten Ceulemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berten Ceulemans. The network helps show where Berten Ceulemans may publish in the future.

Co-authors

The 25 scholars most cited alongside Berten Ceulemans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Berten Ceulemans Line = papers co-authored together Berten Ceulemans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy The American Journal of Human Genetics ·Lieve Claes, Jurgen Del‐Favero, Berten Ceulemans, Lieven Lagae, Christine Van Broeckhoven, Peter De Jonghe Hit paper breakdown →	2001	925
2	Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial The Lancet ·Lieven Lagae, Joseph Sullivan, Kelly G. Knupp, Linda Laux, Tilman Polster, Marina Nikanorova, Orrin Devinsky, J. Helen Cross, Renzo Guerrini, Dinesh Talwar, Ian Miller, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Arun Mistry, Glenn Morrison, Michael Lock, Anupam Agarwal, Wyman W. Lai, Berten Ceulemans Hit paper breakdown →	2019	257
3	Early‐onset absence epilepsy caused by mutations in the glucose transporter GLUT1 Annals of Neurology ·Arvid Suls, Saul A. Mullen, Yvonne Weber, Kristien Verhaert, Berten Ceulemans, Renzo Guerrini, Thomas V. Wuttke, Alberto Salvo‐Vargas, Liesbet Deprez, Lieve Claes, Albena Jordanova, Samuel F. Berkovic, Holger Lerche, Peter De Jonghe, Ingrid E. Scheffer	2009	186
4	Successful use of fenfluramine as an add‐on treatment for Dravet syndrome Epilepsia ·Berten Ceulemans, Marc Boel, Katrien Leyssens, Carolin Van Rossem, Pieter Neels, Philippe G. Jorens, Lieven Lagae	2012	167
5	De novoSCN1Amutations are a major cause of severe myoclonic epilepsy of infancy Human Mutation ·Lieve Claes, Berten Ceulemans, Dominique Audenaert, Katrien Smets, Ann Löfgren, Jurgen Del‐Favero, Sirpa Ala‐Mello, Lina Basel‐Vanagaite, Barbara Plecko, Salmo Raskin, Paul Thiry, Nicole I. Wolf, Christine Van Broeckhoven, Peter De Jonghe	2003	152
6	A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy Neurology ·Dominique Audenaert, Laurence Claes, Berten Ceulemans, Ann Löfgren, Christine Van Broeckhoven, Peter De Jonghe	2003	140
7	Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations Neurology ·Liesbet Deprez, Sarah Weckhuysen, Philip Holmgren, Arvid Suls, Tom Van Dyck, D. Goossens, Jurgen Del‐Favero, Anna Jansen, Kristien Verhaert, Liesbet Lagae, Albena Jordanova, Rudy Van Coster, Simone C. Yendle, Samuel F. Berkovic, Ingrid E. Scheffer, Berten Ceulemans, Peter De Jonghe	2010	123
8	Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy Pediatric Neurology ·Berten Ceulemans, Lieve Claes, Lieven Lagae	2004	112
9	Vagus nerve stimulation for refractory epilepsy: A Belgian multicenter study European Journal of Paediatric Neurology ·Veerle De Herdt, Paul Boon, Berten Ceulemans, Henri Hauman, Lieven Lagae, Benjamin Legros, Bernard Sadzot, Patrick Van Bogaert, Kenou van Rijckevorsel, Hélène Verhelst, Kristl Vonck	2007	111
10	Five‐year extended follow‐up status of 10 patients with Dravet syndrome treated with fenfluramine Epilepsia ·Berten Ceulemans, An‐Sofie Schoonjans, Fabienne Marchau, Bernard P. Paelinck, Lieven Lagae	2016	98
11	Non-EEG seizure detection systems and potential SUDEP prevention: State of the art Seizure ·Anouk Van de Vel, Kris Cuppens, Bert Bonroy, Milica Milošević, Katrien Jansen, Sabine Van Huffel, Bart Vanrumste, Patrick Cras, Lieven Lagae, Berten Ceulemans	2016	96
12	Microdeletions involving theSCN1A gene may be common inSCN1A-mutation-negative SMEI patients Human Mutation ·Arvid Suls, Kristl G. Claeys, D. Goossens, B Harding, Rob van Luijk, Stefaan Scheers, Liesbet Deprez, Dominique Audenaert, Tine Van Dyck, Sabine Beeckmans, Iris Smouts, Berten Ceulemans, Lieven Lagae, Gunnar Buyse, Nina Barišić, Jean‐Paul Misson, J. Wauters, Jurgen Del‐Favero, Peter De Jonghe, Lieve Claes	2006	90
13	Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome JAMA Neurology ·Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine Nickels, Lieven Lagae, Renzo Guerrini, Sameer M. Zuberi, Rima Nabbout, Kate Riney, Svetlana Shore, Anupam Agarwal, Michael Lock, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Ronald L. Davis, António Gil‐Nagel	2022	87
14	Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine PLoS ONE ·Yifan Zhang, Angéla Kecskés, Daniëlle Copmans, Mélanie Langlois, Alexander D. Crawford, Berten Ceulemans, Lieven Lagae, Peter de Witte, Camila V. Esguerra	2015	86
15	Low‐dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients European Journal of Neurology ·An‐Sofie Schoonjans, Bernard P. Paelinck, Fabienne Marchau, Boudewijn Gunning, Arnold R. Gammaitoni, Bradley S. Galer, Lieven Lagae, Berten Ceulemans	2016	85
16	Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial Neuromuscular Disorders ·Gunnar Buyse, Nathalie Goemans, M. van den Hauwe, Daisy Thijs, Imelda J. M. de Groot, Ulrike Schara, Berten Ceulemans, Thomas Meier, Luc Mertens	2011	85
17	Non-EEG seizure-detection systems and potential SUDEP prevention: State of the art Seizure ·Anouk Van de Vel, Kris Cuppens, Bert Bonroy, Milica Milošević, Katrien Jansen, Sabine Van Huffel, Bart Vanrumste, Lieven Lagae, Berten Ceulemans	2013	84
18	Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial Seizure ·Lieven Lagae, Gunnar Buyse, Berten Ceulemans	2004	82
19	Subtelomeric deletions detected in patients with idiopathic mental retardation using multiplex ligation-dependent probe amplification (MLPA) Human Mutation ·Liesbeth Rooms, Edwin Reyniers, Rob van Luijk, Stefaan Scheers, J. Wauters, Berten Ceulemans, Jenneke van den Ende, Yolande van Bever, R. Frank Kooy	2003	79
20	Steroids in intractable childhood epilepsy: Clinical experience and review of the literature Seizure ·Helene Verhelst, Paul Boon, Gunnar Buyse, Berten Ceulemans, Marc D’Hooghe, Linda De Meırleır, Danièle Hasaerts, Anna Jansen, Lieven Lagae, Alfred Meurs, Rudy Van Coster, Kristl Vonck	2005	76

About Berten Ceulemans

Berten Ceulemans is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Cognitive Neuroscience, Genetics and Molecular Biology, having authored 155 papers that have together received 5.5k indexed citations. Recurring topics across this work include Epilepsy research and treatment (61 papers), EEG and Brain-Computer Interfaces (27 papers), Pharmacological Effects and Toxicity Studies (20 papers), Genetics and Neurodevelopmental Disorders (19 papers), Neuroscience and Neuropharmacology Research (11 papers), Genomic variations and chromosomal abnormalities (8 papers), Ion channel regulation and function (6 papers) and Metabolism and Genetic Disorders (6 papers). The work is most often cited by research in Psychiatry and Mental health (2.9k citations), Cellular and Molecular Neuroscience (1.3k citations), Pediatrics, Perinatology and Child Health (1.1k citations), Clinical Biochemistry (291 citations) and Cognitive Neuroscience (821 citations). Berten Ceulemans has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Lieven Lagae, Peter De Jonghe, Lieve Claes, Christine Van Broeckhoven, Jurgen Del‐Favero, An‐Sofie Schoonjans, Anouk Van de Vel, Bart Vanrumste, Sabine Van Huffel and Kris Cuppens. Their work appears in journals such as European Journal of Paediatric Neurology, Epilepsia, Seizure, Developmental Medicine & Child Neurology and Epilepsy & Behavior.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Berten Ceulemans

Impact in

Papers in i

In The Last Decade

Berten Ceulemans

Berten Ceulemans's Hit Papers

Peers

Countries citing papers authored by Berten Ceulemans

Fields of papers citing papers by Berten Ceulemans

All Works

About Berten Ceulemans

Explore authors with similar magnitude of impact

Papers in